Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Reset all filters
01 4Sanofi
02 3GSK
Reset all filters
01 7PERTUSSIS
Reset all filters
01 7SUSPENSION
Reset all filters
01 1ADACEL
02 1ADACEL-POLIO
03 1BOOSTRIX
04 1BOOSTRIX-POLIO
05 1INFANRIX HEXA
06 1PENTACEL
07 1QUADRACEL
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : ADACEL
Dosage Form : SUSPENSION
Dosage Strength : 2.5MCG/0.5ML
Packaging : 1X0.5ML/5X0.5ML
Approval Date :
Application Number : 2240255
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : PENTACEL
Dosage Form : SUSPENSION
Dosage Strength : 20MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2534797
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : QUADRACEL
Dosage Form : SUSPENSION
Dosage Strength : 20MCG/0.5ML
Packaging :
Approval Date :
Application Number : 2534789
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : ADACEL-POLIO
Dosage Form : SUSPENSION
Dosage Strength : 2.5MCG/0.5ML
Packaging : 0.5ML
Approval Date :
Application Number : 2352044
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : BOOSTRIX
Dosage Form : SUSPENSION
Dosage Strength : 8MCG/0.5ML
Packaging : 10X0.5ML (PREFILLED SYRINGE)
Approval Date :
Application Number : 2247600
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : INFANRIX HEXA
Dosage Form : SUSPENSION
Dosage Strength : 25MCG/0.5ML
Packaging : 10X0.5ML
Approval Date :
Application Number : 2253852
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : BOOSTRIX-POLIO
Dosage Form : SUSPENSION
Dosage Strength : 8MCG/0.5ML
Packaging : 0.5ML/10X0.5ML
Approval Date :
Application Number : 2312557
Regulatory Info : Schedule D
Registration Country : Canada